rs73339979

This is a regulatory region variant variant in the GLTPD2 gene.

GWAS Catalog Trait Associations (3)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

total cholesterol measurement

Allele C
OR 0.05
p 6.0e-17
N 99,432
Large GWAS
African American or Afro-Caribbean, African unspecified
Allele C
OR 0.06
p 8.0e-15
N 297,626
Major Consortium StudyLarge GWAS
multi-ancestry
Verma A et al. Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. Science (new York, N.y.) 385(6706):eadj1182 (2024)
Allele C
OR 0.05
p 2.0e-15
N 112,265
Major Consortium StudyLarge GWAS
African American or Afro-Caribbean

low density lipoprotein cholesterol measurement

Allele C
OR 0.05
p 4.0e-12
N 99,432
Large GWAS
African American or Afro-Caribbean, African unspecified
Allele C
OR 0.05
p 4.0e-11
N 297,626
Major Consortium StudyLarge GWAS
multi-ancestry

triglyceride measurement

Verma A et al. Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. Science (new York, N.y.) 385(6706):eadj1182 (2024)
Allele G
OR 0.04
p 4.0e-13
N 107,786
Major Consortium StudyLarge GWAS
African American or Afro-Caribbean

About GLTPD2

Predicted to enable ceramide 1-phosphate binding activity and ceramide 1-phosphate transfer activity. Predicted to be involved in ceramide transport and intermembrane lipid transfer. Predicted to be located in cytoplasm. Predicted to be active in cytosol. [provided by Alliance of Genome Resources, Jul 2025]

View all GLTPD2 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…